Skip to main content
Signal8

REG-Capital Increase in Genmab as a Result of Employee Warrant Exercise

$GMABPress releaseJun 16, 2026, 3:12 PM ETRead the release

Genmab A/S will increase its share capital by 185 shares following the exercise of employee warrants. The shares were subscribed in cash at DKK 1,334.50 per share, generating total proceeds of approximately DKK 0.2 million, representing less than 0.001% of the company's share capital.

Key figures

Proceeds dkk
DKK 0.2 million
Shares exercised
185
Exercise price dkk
DKK 1,334.50
Total nominal capital dkk
62353252

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.